{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35424427", "DateRevised": {"Year": "2022", "Month": "04", "Day": "16"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "01", "Day": "28"}], "Language": ["eng"], "ELocationID": ["10.1039/d0ra10453a"], "Journal": {"ISSN": "2046-2069", "JournalIssue": {"Volume": "11", "Issue": "9", "PubDate": {"Year": "2021", "Month": "Jan", "Day": "25"}}, "Title": "RSC advances", "ISOAbbreviation": "RSC Adv"}, "ArticleTitle": "DiaNat-DB: a molecular database of antidiabetic compounds from medicinal plants.", "Pagination": {"StartPage": "5172", "EndPage": "5178", "MedlinePgn": "5172-5178"}, "Abstract": {"AbstractText": ["Natural products are an invaluable source of molecules with a large variety of biological activities. Interest in natural products in drug discovery is documented in an increasing number of publications of bioactive secondary metabolites. Among those, medicinal plants are one of the most studied for this endeavor. An ever thriving area of opportunity within the field concerns the discovery of antidiabetic natural products. As a result, a vast amount of secondary metabolites are isolated from medicinal plants used against diabetes mellitus but whose information has not been organized systematically yet. Several research articles enumerate antidiabetic compounds, but the lack of a chemical database for antidiabetic metabolites limits their application in drug development. In this work, we present DiaNat-DB, a comprehensive collection of 336 molecules from medicinal plants reported to have <i>in vitro</i> or <i>in vivo</i> antidiabetic activity. We also discuss a chemoinformatic analysis of DiaNat-DB to compare antidiabetic drugs and natural product databases. To further explore the antidiabetic chemical space based on DiaNat compounds, we searched for analogs in ZINC15, an extensive database listing commercially available compounds. This work will help future analyses, design, and development of new antidiabetic drugs. DiaNat-DB and its ZINC15 analogs are freely available at http://rdu.iquimica.unam.mx/handle/20.500.12214/1186."], "CopyrightInformation": "This journal is \u00a9 The Royal Society of Chemistry."}, "AuthorList": [{"Identifier": ["0000-0002-8938-1318"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Instituto de Qu\u00edmica, Universidad Nacional Aut\u00f3noma de M\u00e9xico Mexico City 04510 Mexico amadariaga@iquimica.unam.mx kmtzm@unam.mx +52 55 56224770 ext. 46614."}], "LastName": "Madariaga-Maz\u00f3n", "ForeName": "Abraham", "Initials": "A"}, {"Identifier": ["0000-0001-8640-6690"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Instituto de Qu\u00edmica, Universidad Nacional Aut\u00f3noma de M\u00e9xico Mexico City 04510 Mexico amadariaga@iquimica.unam.mx kmtzm@unam.mx +52 55 56224770 ext. 46614."}], "LastName": "Naveja", "ForeName": "Jos\u00e9 J", "Initials": "JJ"}, {"Identifier": ["0000-0003-4940-1107"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "DIFACQUIM Research Group, Department of Pharmacy, School of Chemistry, Universidad Nacional Aut\u00f3noma de M\u00e9xico Mexico City 04510 Mexico."}], "LastName": "Medina-Franco", "ForeName": "Jos\u00e9 L", "Initials": "JL"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Instituto de Qu\u00edmica, Universidad Nacional Aut\u00f3noma de M\u00e9xico Mexico City 04510 Mexico amadariaga@iquimica.unam.mx kmtzm@unam.mx +52 55 56224770 ext. 46614."}], "LastName": "Noriega-Colima", "ForeName": "Karla O", "Initials": "KO"}, {"Identifier": ["0000-0002-6974-7941"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Instituto de Qu\u00edmica, Universidad Nacional Aut\u00f3noma de M\u00e9xico Mexico City 04510 Mexico amadariaga@iquimica.unam.mx kmtzm@unam.mx +52 55 56224770 ext. 46614."}], "LastName": "Martinez-Mayorga", "ForeName": "Karina", "Initials": "K"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "RSC Adv", "NlmUniqueID": "101581657", "ISSNLinking": "2046-2069"}, "CoiStatement": "The authors declare no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010;33(suppl 1):S62\u2013S69. doi: 10.2337/dc10-S062.", "ArticleIdList": ["10.2337/dc10-S062", "PMC2797383", "20042775"]}, {"Citation": "Zheng Y. Ley S. H. Hu F. B. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat. Rev. Endocrinol. 2018;14(2):88\u201398. doi: 10.1038/nrendo.2017.151.", "ArticleIdList": ["10.1038/nrendo.2017.151", "29219149"]}, {"Citation": "IDF Diabetes Atlas 9th edition 2019 [Internet], cited 2020 Nov 17, https://diabetesatlas.org/en/"}, {"Citation": "Forbes J. M. Cooper M. E. Mechanisms of diabetic complications. Physiol. Rev. 2013;93(1):137\u2013188. doi: 10.1152/physrev.00045.2011.", "ArticleIdList": ["10.1152/physrev.00045.2011", "23303908"]}, {"Citation": "van Herpt T. T. W. Lemmers R. F. H. van Hoek M. Langendonk J. G. Erdtsieck R. J. Bravenboer B. et al. Introduction of the DiaGene study: clinical characteristics, pathophysiology and determinants of vascular complications of type 2 diabetes. Diabetol. Metab. Syndr. 2017;9:47. doi: 10.1186/s13098-017-0245-x.", "ArticleIdList": ["10.1186/s13098-017-0245-x", "PMC5477157", "28649285"]}, {"Citation": "Cheng A. Y. Y. Fantus I. G. Oral antihyperglycemic therapy for type 2 diabetes mellitus. CMAJ. 2005;172(2):213\u2013226.", "ArticleIdList": ["PMC543986", "15655244"]}, {"Citation": "Yakary\u0131lmaz F. D. \u00d6zt\u00fcrk Z. A. Treatment of type 2 diabetes mellitus in the elderly. World J. Diabetes. 2017;8(6):278\u2013285. doi: 10.4239/wjd.v8.i6.278.", "ArticleIdList": ["10.4239/wjd.v8.i6.278", "PMC5483426", "28694928"]}, {"Citation": "Claggett B. Lachin J. M. Hantel S. Fitchett D. Inzucchi S. E. Woerle H. J. et al. Long-Term Benefit of Empagliflozin on Life Expectancy in Patients With Type 2 Diabetes Mellitus and Established Cardiovascular Disease. Circulation. 2018 Oct 9;138(15):1599\u20131601.", "ArticleIdList": ["30354516"]}, {"Citation": "Loraine S. and Mendoza-Espinoza J. A., Las plantas medicinales en la lucha contra el c\u00e1ncer, relevancia para M\u00e9xico, Revista Mexicana de Ciencias Farmac\u00e9uticas, 2010"}, {"Citation": "Bankova V. Chemical diversity of propolis and the problem of standardization. J. Ethnopharmacol. 2005;100(1\u20132):114\u2013117. doi: 10.1016/j.jep.2005.05.004.", "ArticleIdList": ["10.1016/j.jep.2005.05.004", "15993016"]}, {"Citation": "Newman D. J. Cragg G. M. Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019. J. Nat. Prod. 2020;83(3):770\u2013803. doi: 10.1021/acs.jnatprod.9b01285.", "ArticleIdList": ["10.1021/acs.jnatprod.9b01285", "32162523"]}, {"Citation": "Eddouks M. Chattopadhyay D. De Feo V. Cho W. C. Medicinal plants in the prevention and treatment of chronic diseases. J. Evidence-Based Complementary Altern. Med. 2012;2012:458274.", "ArticleIdList": ["PMC3457723", "23024691"]}, {"Citation": "Mukherjee P. K. Maiti K. Mukherjee K. Houghton P. J. Leads from Indian medicinal plants with hypoglycemic potentials. J. Ethnopharmacol. 2006;106(1):1\u201328. doi: 10.1016/j.jep.2006.03.021.", "ArticleIdList": ["10.1016/j.jep.2006.03.021", "16678368"]}, {"Citation": "Escand\u00f3n-Rivera S. M. Mata R. Andrade-Cetto A. Molecules Isolated from Mexican Hypoglycemic Plants: A Review. Molecules. 2020;25(18):4145. doi: 10.3390/molecules25184145.", "ArticleIdList": ["10.3390/molecules25184145", "PMC7571036", "32927754"]}, {"Citation": "Madariaga-Maz\u00f3n A. Hern\u00e1ndez-Alvarado R. B. Noriega-Colima K. O. Osnaya-Hern\u00e1ndez A. Martinez-Mayorga K. Toxicity of secondary metabolites. Phys. Sci. Rev. 2019;4(12):20180116."}, {"Citation": "Meetei P. A. Singh P. Nongdam P. Prabhu N. P. Rathore R. Vindal V. NeMedPlant: a database of therapeutic applications and chemical constituents of medicinal plants from north-east region of India. Bioinformation. 2012;8(4):209\u2013211. doi: 10.6026/97320630008209.", "ArticleIdList": ["10.6026/97320630008209", "PMC3302005", "22419844"]}, {"Citation": "P\u00e9rez-S\u00e1nchez H. den-Haan H. Pe\u00f1a-Garc\u00eda J. Lozano-S\u00e1nchez J. Mart\u00ednez Moreno M. E. S\u00e1nchez-P\u00e9rez A. et al. DIA-DB: A Database and Web Server for the Prediction of Diabetes Drugs. J. Chem. Inf. Model. 2020;60(9):4124\u20134130. doi: 10.1021/acs.jcim.0c00107.", "ArticleIdList": ["10.1021/acs.jcim.0c00107", "32692571"]}, {"Citation": "Khatoon A. Rashid I. Shaikh S. Rizvi S. M. D. Shakil S. Pathak N. et al. ADNCD: a compendious database on anti-diabetic natural compounds focusing on mechanism of action. 3 Biotech. 2018;8(8):361. doi: 10.1007/s13205-018-1385-x.", "ArticleIdList": ["10.1007/s13205-018-1385-x", "PMC6081838", "30105186"]}, {"Citation": "Makheswari M. U. Sudarsanam D. Database on Antidiabetic indigenous plants of Tamil Nadhu, India. Int. J. Pharm. Sci. Rev. Res. 2012;3(2):287\u2013293."}, {"Citation": "Weininger D. SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules. J. Chem. Inf. Model. 1988;28(1):31\u201336. doi: 10.1021/ci00057a005.", "ArticleIdList": ["10.1021/ci00057a005"]}, {"Citation": "Wishart D. S. Feunang Y. D. Guo A. C. Lo E. J. Marcu A. Grant J. R. et al. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2018;46(D1):D1074\u2013D1082. doi: 10.1093/nar/gkx1037.", "ArticleIdList": ["10.1093/nar/gkx1037", "PMC5753335", "29126136"]}, {"Citation": "Lipinski C. A. Lombardo F. Dominy B. W. Feeney P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Delivery Rev. 2001;46(1\u20133):3\u201326. doi: 10.1016/S0169-409X(00)00129-0.", "ArticleIdList": ["10.1016/S0169-409X(00)00129-0", "11259830"]}, {"Citation": "Veber D. F. Johnson S. R. Cheng H.-Y. Smith B. R. Ward K. W. Kopple K. D. Molecular properties that influence the oral bioavailability of drug candidates. J. Med. Chem. 2002;45(12):2615\u20132623. doi: 10.1021/jm020017n.", "ArticleIdList": ["10.1021/jm020017n", "12036371"]}, {"Citation": "M\u00e9ndez-Lucio O. Medina-Franco J. L. The many roles of molecular complexity in drug discovery. Drug Discovery Today. 2017;22(1):120\u2013126. doi: 10.1016/j.drudis.2016.08.009.", "ArticleIdList": ["10.1016/j.drudis.2016.08.009", "27575998"]}, {"Citation": "Wei W. Cherukupalli S. Jing L. Liu X. Zhan P. Fsp3: A new parameter for drug-likeness. Drug Discovery Today. 2020;25:1839\u20131845. doi: 10.1016/j.drudis.2020.07.017.", "ArticleIdList": ["10.1016/j.drudis.2020.07.017", "32712310"]}, {"Citation": "Bemis G. W. Murcko M. A. The properties of known drugs. 1. Molecular frameworks. J. Med. Chem. 1996;39(15):2887\u20132893. doi: 10.1021/jm9602928.", "ArticleIdList": ["10.1021/jm9602928", "8709122"]}, {"Citation": "Maaten L. Hinton G. Visualizing Data using t-SNE. J. Mach. Learn. Res. 2008;9:2579\u20132605."}, {"Citation": "Naveja J. J. Medina-Franco J. L. Consistent Cell-selective Analog Series as Constellation Luminaries in Chemical Space. Mol. Inf. 2020:2000061. doi: 10.1002/minf.202000061.", "ArticleIdList": ["10.1002/minf.202000061", "32390313"]}, {"Citation": "Naveja J. J. Vogt M. Stumpfe D. Medina-Franco J. L. Bajorath J. Systematic Extraction of Analogue Series from Large Compound Collections Using a New Computational Compound-Core Relationship Method. ACS Omega. 2019;4(1):1027\u20131032. doi: 10.1021/acsomega.8b03390.", "ArticleIdList": ["10.1021/acsomega.8b03390", "PMC6648924", "31459378"]}, {"Citation": "Naveja J. J. Pil\u00f3n-Jim\u00e9nez B. A. Bajorath J. Medina-Franco J. L. A general approach for retrosynthetic molecular core analysis. J. Cheminf. 2019;11(1):61.", "ArticleIdList": ["PMC6760108", "33430974"]}, {"Citation": "Naveja J. J. Medina-Franco J. L. Finding constellations in chemical space through core analysis. Front. Chem. 2019;7:510. doi: 10.3389/fchem.2019.00510.", "ArticleIdList": ["10.3389/fchem.2019.00510", "PMC6646408", "31380353"]}, {"Citation": "Sterling T. Irwin J. J. ZINC 15--Ligand Discovery for Everyone. J. Chem. Inf. Model. 2015;55(11):2324\u20132337. doi: 10.1021/acs.jcim.5b00559.", "ArticleIdList": ["10.1021/acs.jcim.5b00559", "PMC4658288", "26479676"]}, {"Citation": "Chen Y. de Bruyn Kops C. Kirchmair J. Data Resources for the Computer-Guided Discovery of Bioactive Natural Products. J. Chem. Inf. Model. 2017;57(9):2099\u20132111. doi: 10.1021/acs.jcim.7b00341.", "ArticleIdList": ["10.1021/acs.jcim.7b00341", "28853576"]}, {"Citation": "Medina-Franco J. L. Towards a unified Latin American Natural Products Database: LANaPD. Future Sci. OA. 2020;6(8):FSO468. doi: 10.2144/fsoa-2020-0068.", "ArticleIdList": ["10.2144/fsoa-2020-0068", "PMC7491008", "32983559"]}, {"Citation": "Chen Y. Kirchmair J. Cheminformatics in Natural Product-Based Drug Discovery. Mol. Inf. 2020:2000171. doi: 10.1002/minf.202000171.", "ArticleIdList": ["10.1002/minf.202000171", "PMC7757247", "32725781"]}, {"Citation": "Martinez-Mayorga K. Madariaga-Mazon A. Medina-Franco J. L. Maggiora G. The impact of chemoinformatics on drug discovery in the pharmaceutical industry. Expert Opin. Drug Discovery. 2020;15(3):293\u2013306. doi: 10.1080/17460441.2020.1696307.", "ArticleIdList": ["10.1080/17460441.2020.1696307", "31965870"]}, {"Citation": "Tran T. D. Ogbourne S. M. Brooks P. R. S\u00e1nchez-Cruz N. Medina-Franco J. L. Quinn R. J. Lessons from Exploring Chemical Space and Chemical Diversity of Propolis Components. Int. J. Mol. Sci. 2020;21(14):4988. doi: 10.3390/ijms21144988.", "ArticleIdList": ["10.3390/ijms21144988", "PMC7404124", "32679731"]}, {"Citation": "Al Sharie A. H. El-Elimat T. Al Zu\u2019bi Y. O. Aleshawi A. J. Medina-Franco J. L. Chemical space and diversity of seaweed metabolite database (SWMD): A cheminformatics study. J. Mol. Graphics Modell. 2020:107702. doi: 10.1016/j.jmgm.2020.107702.", "ArticleIdList": ["10.1016/j.jmgm.2020.107702", "32810730"]}, {"Citation": "L\u00f3pez-L\u00f3pez E. Bajorath J. Medina-Franco J. L. Informatics for chemistry, biology, and biomedical sciences. J. Chem. Inf. Model. 2020 doi: 10.1021/acs.jcim.0c01301.", "ArticleIdList": ["10.1021/acs.jcim.0c01301", "33382611"]}, {"Citation": "Martinez-Mayorga K. Characterization of a comprehensive flavor database. J. Chemom. 2011;25:550\u2013560. doi: 10.1002/cem.1399.", "ArticleIdList": ["10.1002/cem.1399"]}, {"Citation": "G\u00f3mez-Jim\u00e9nez G. Gonzalez-Ponce K. Castillo-Pazos D. J. Madariaga-Mazon A. Barroso-Flores J. Cortes-Guzman F. Martinez-Mayorga K. The OECD Principles for (Q)SAR Models in the Context of Knowledge Discovery in Databases (KDD) Adv. Protein Chem. Struct. Biol. 2018;113:85\u2013117.", "ArticleIdList": ["30149907"]}, {"Citation": "Hern\u00e1ndez-Alvarado R. B. Madariaga-Maz\u00f3n A. Martinez-Mayorga K. Prediction of toxicity of secondary metabolites. Phys. Sci. Rev. 2019;4(11):20180107."}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "12", "Day": "12"}, {"Year": "2021", "Month": "1", "Day": "15"}, {"Year": "2022", "Month": "4", "Day": "15", "Hour": "5", "Minute": "28"}, {"Year": "2021", "Month": "1", "Day": "28", "Hour": "0", "Minute": "0"}, {"Year": "2021", "Month": "1", "Day": "28", "Hour": "0", "Minute": "1"}, {"Year": "2021", "Month": "1", "Day": "28"}], "PublicationStatus": "epublish", "ArticleIdList": ["35424427", "PMC8694643", "10.1039/d0ra10453a", "d0ra10453a"]}}], "PubmedBookArticle": []}